| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Coleman Mark is a Director at Axsome Therapeutics, Inc.. Recent SEC Form 4 filings include 10 buys and 7 sells.
Estimated insider holdings value: $11.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 1,575 | $127.28 | $200,466.30 | +1.1% | +14.1% | - | |
| May 28, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 7,500 | $104.45 | $783,375.00 | -7.2% | +17.6% | - | |
| May 20, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 3,000 | $107.49 | $322,473.00 | -5.3% | +2.6% | - | |
| May 29, 2024 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 10,497 | $75.17 | $789,107.29 | -23.4% | +18.2% | +39.1% | |
| Sep 15, 2023 | AXSM Axsome Therapeutics, Inc. | Director | Sale+OE | 29,588 | $75.18 | $2,224,430.37 | -6.5% | -2.6% | +24.5% | |
| Nov 18, 2021 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 1,430 | $35.09 | $50,180.73 | +0.2% | -11.2% | +57.8% | |
| May 12, 2021 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 500 | $58.15 | $29,075.00 | +0.1% | -58.3% | -55.6% | |
| Jun 29, 2020 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 650 | $78.50 | $51,025.00 | +0.2% | - | - | |
| Jun 26, 2019 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 16,200 | $23.10 | $374,280.00 | +1.2% | - | - | |
| May 13, 2019 | AXSM Axsome Therapeutics, Inc. | Director | Buy | 4,650 | $21.44 | $99,696.00 | +0.7% | - | - |